SecBot SecBot

ADIL

Azora Therapeutics, Inc. (DE)
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001513525 Biotech & Drug Discovery
No price
Market cap
$9.7M
Nano cap
Median target
$8.00
range $6.00–11.00
Since first trade
−19.8%
from $5.05 · Oct 28
30 days
−19.8%
from $5.05
Range since listing
$3.81–5.05
−20% from high · low Oct 30
Avg volume 6D
83.2K
shares / day
Short interest
179.6K
≈6.8% of shares · −2.0%
Days to cover
4.5
at average volume
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
18
analyzed by SecBot
SecBot read BEARISH 15 reports · 90 days
Balance 5 bearish · 2 bullish · 8 neutral oldest → newest, height = score
Avg score ·High conf. 14/15

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InstitutionsBULLISH

    Q3 2026: 4 added (0 new), 1 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate −$1.310 → −$2.575 over 90 days.

  • Short sellersSTEADY

    Short interest −2.0% to 179.6K shares. 4.5 days to cover, ≈6.8% of shares.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 29.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
JANE STREET GROUP, LLCADD53,952$216.3K
GEODE CAPITAL MANAGEMENT, LLCADD21,546$86.4K
VANGUARD FIDUCIARY TRUST CODOUBLED15,879$63.7K
VANGUARD CAPITAL MANAGEMENT LLCADD10,407$41.7K
UBS Group AGNEAR_EXIT1,688$6.8K
UBS Group AGDOUBLED19,147$49.0K
GEODE CAPITAL MANAGEMENT, LLCTRIM12,393$31.7K
VANGUARD CAPITAL MANAGEMENT LLCDOUBLED5,831$14.9K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Aug 2026
Recent actions
DateFirmActionRating
Aug 3, 2026Alliance Global Partners
INITIATE
INITIATEBuy
Jun 15, 2026LUCID CAPITAL MARKETS
INITIATE
INITIATEBuy

Earnings setup

Estimates
−$2.58
EPS estimate, this quarter
−97%
estimate change, 90 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$2.58-$5.00–-$0.15+48.5%$0.00
Next Q-$2.59-$5.00–-$0.18+48.2%$0.00
Current FY-$1.05-$1.05–-$1.05No data$0.00
Next FY-$7.45-$14.25–-$0.65+47.7%$0.00
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.

SecBot reports

18 filings · 5 press releases · 3 bullish · 6 bearish · 9 neutral
All ADIL filing & press-release reports (23)